Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Leukemia & Lymphoma
|
June 14, 2003
Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab
Raymond Wong, Marcos de Lima, Daniel Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 11, 2002
Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia
Borje S Andersson, Peter F Thall, Timothy Madden, et al.
British Journal of Haematology
|
June 26, 2003
Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation
Raymond Wong, Guillermo Z Beguelin, Marcos de Lima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 26, 2018
Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes
Lucie M Turcotte, Tao Wang, Michael T Hemmer, et al.
Cancer
|
February 25, 2003
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias
Marcos de Lima, Farhad Ravandi, Munir Shahjahan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 16, 2002
A survey of diagnosis, management, and grading of chronic GVHD
Stephanie J Lee, Georgia Vogelsang, Andrew Gilman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 16, 2007
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule
Timothy Madden, Marcos de Lima, Neil Thapar, et al.
American Journal of Epidemiology
|
May 5, 2017
Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-Learning
Elizabeth F Krakow, Michael Hemmer, Tao Wang, et al.
Blood
|
August 9, 2003
CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans
Marta Stanzani, Sergio L R Martins, Rima M Saliba, et al.
Blood
|
January 17, 2004
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters
Maha El-Zimaity, Rima Saliba, Kawah Chan, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Leukemia & Lymphoma
|
June 14, 2003
Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab
Raymond Wong, Marcos de Lima, Daniel Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 11, 2002
Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia
Borje S Andersson, Peter F Thall, Timothy Madden, et al.
British Journal of Haematology
|
June 26, 2003
Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation
Raymond Wong, Guillermo Z Beguelin, Marcos de Lima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 26, 2018
Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes
Lucie M Turcotte, Tao Wang, Michael T Hemmer, et al.
Cancer
|
February 25, 2003
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias
Marcos de Lima, Farhad Ravandi, Munir Shahjahan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 16, 2002
A survey of diagnosis, management, and grading of chronic GVHD
Stephanie J Lee, Georgia Vogelsang, Andrew Gilman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 16, 2007
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule
Timothy Madden, Marcos de Lima, Neil Thapar, et al.
American Journal of Epidemiology
|
May 5, 2017
Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-Learning
Elizabeth F Krakow, Michael Hemmer, Tao Wang, et al.
Blood
|
August 9, 2003
CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans
Marta Stanzani, Sergio L R Martins, Rima M Saliba, et al.
Blood
|
January 17, 2004
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters
Maha El-Zimaity, Rima Saliba, Kawah Chan, et al.
Page
of 8